These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38480925)

  • 1. MYC activates transcriptional enhancers to drive cancer progression.
    Nat Genet; 2024 Apr; 56(4):567-568. PubMed ID: 38480925
    [No Abstract]   [Full Text] [Related]  

  • 2. The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer.
    Lancho O; Herranz D
    Trends Cancer; 2018 Dec; 4(12):810-822. PubMed ID: 30470303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D genomic analysis reveals novel enhancer-hijacking caused by complex structural alterations that drive oncogene overexpression.
    Mortenson KL; Dawes C; Wilson ER; Patchen NE; Johnson HE; Gertz J; Bailey SD; Liu Y; Varley KE; Zhang X
    Nat Commun; 2024 Jul; 15(1):6130. PubMed ID: 39033128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC activity at enhancers drives prognostic transcriptional programs through an epigenetic switch.
    Jakobsen ST; Jensen RAM; Madsen MS; Ravnsborg T; Vaagenso CS; Siersbæk MS; Einarsson H; Andersson R; Jensen ON; Siersbæk R
    Nat Genet; 2024 Apr; 56(4):663-674. PubMed ID: 38454021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional suppression of HLA-B expression by c-Myc is mediated through the core promoter elements.
    Peltenburg LT; Schrier PI
    Immunogenetics; 1994; 40(1):54-61. PubMed ID: 8206526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory elements in the immunoglobulin kappa locus induce c-myc activation and the promoter shift in Burkitt's lymphoma cells.
    Polack A; Feederle R; Klobeck G; Hörtnagel K
    EMBO J; 1993 Oct; 12(10):3913-20. PubMed ID: 8404859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancers and MYC interplay in hematopoiesis.
    Benetatos L; Benetatou A; Vartholomatos G
    J Mol Med (Berl); 2020 Apr; 98(4):471-481. PubMed ID: 32144465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism.
    Schuijers J; Manteiga JC; Weintraub AS; Day DS; Zamudio AV; Hnisz D; Lee TI; Young RA
    Cell Rep; 2018 Apr; 23(2):349-360. PubMed ID: 29641996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cooperative action of multiple cis-acting elements is required for N-myc expression in branchial arches: specific contribution of GATA3.
    Potvin E; Beuret L; Cadrin-Girard JF; Carter M; Roy S; Tremblay M; Charron J
    Mol Cell Biol; 2010 Nov; 30(22):5348-63. PubMed ID: 20855530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines.
    Roland J; Morello D
    Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory elements in the immunoglobulin heavy chain gene 3'-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells.
    Wang J; Boxer LM
    J Biol Chem; 2005 Apr; 280(13):12766-73. PubMed ID: 15687498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation.
    Shi J; Whyte WA; Zepeda-Mendoza CJ; Milazzo JP; Shen C; Roe JS; Minder JL; Mercan F; Wang E; Eckersley-Maslin MA; Campbell AE; Kawaoka S; Shareef S; Zhu Z; Kendall J; Muhar M; Haslinger C; Yu M; Roeder RG; Wigler MH; Blobel GA; Zuber J; Spector DL; Young RA; Vakoc CR
    Genes Dev; 2013 Dec; 27(24):2648-62. PubMed ID: 24285714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hold the MYCrophone: MYC Invades Enhancers to Control Cancer-Type Gene Programs.
    MacPherson-Hawthorne K; Sears RC
    Cancer Res; 2024 Jul; 84(14):2227-2228. PubMed ID: 38695859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
    Desbarats L; Gaubatz S; Eilers M
    Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional amplification in tumor cells with elevated c-Myc.
    Lin CY; Lovén J; Rahl PB; Paranal RM; Burge CB; Bradner JE; Lee TI; Young RA
    Cell; 2012 Sep; 151(1):56-67. PubMed ID: 23021215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor.
    Wang C; Mayer JA; Mazumdar A; Fertuck K; Kim H; Brown M; Brown PH
    Mol Endocrinol; 2011 Sep; 25(9):1527-38. PubMed ID: 21835891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state.
    Poli V; Fagnocchi L; Fasciani A; Cherubini A; Mazzoleni S; Ferrillo S; Miluzio A; Gaudioso G; Vaira V; Turdo A; Gaggianesi M; Chinnici A; Lipari E; Bicciato S; Bosari S; Todaro M; Zippo A
    Nat Commun; 2018 Mar; 9(1):1024. PubMed ID: 29523784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse Models of
    Ferrad M; Ghazzaui N; Issaoui H; Cook-Moreau J; Denizot Y
    Front Immunol; 2020; 11():1564. PubMed ID: 32793219
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Zimmerman MW; Liu Y; He S; Durbin AD; Abraham BJ; Easton J; Shao Y; Xu B; Zhu S; Zhang X; Li Z; Weichert-Leahey N; Young RA; Zhang J; Look AT
    Cancer Discov; 2018 Mar; 8(3):320-335. PubMed ID: 29284669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of noncoding RNAs encoded by a novel MYC enhancers inhibits the proliferation of human hepatic carcinoma cells in vitro.
    Choi HI; An GY; Yoo E; Baek M; Chai JC; Binas B; Lee YS; Jung KH; Chai YG
    Sci Rep; 2022 Jan; 12(1):855. PubMed ID: 35039581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.